Overview

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

Status:
Active, not recruiting

Trial end date:
2022-08-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to examine the effect of prolonged (72 hour) administration of glucagon compared to placebo on energy expenditure in healthy, non-diabetic, obese subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Translational Research Institute for Metabolism and Diabetes, Florida

Treatments:

Glucagon
Glucagon-Like Peptide 1